Medical specialists from France tagged as investigators in clinical trials studying Hyperoxaluria, Primary
Total 11 results
-
Alexandre KARRAS, PrSeen in:
- Paris, Hopital Europeen G. Pompidou
Trials:- NCT03290456 (Principal Investigator)
- NCT06225882 (Principal Investigator)
-
Aude SERVAIS, PU PHSeen in:
- Paris, CHU Paris - Hôpital Necker-Enfants Malades
Trials:- NCT03919981 (Principal Investigator)
- NCT06225882 (Principal Investigator)
-
Bruno MOULIN, MD, PhDSeen in:
- Strasbourg, Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg
Trials:- NCT05077163 (Principal Investigator)
- NCT05107830 (Principal Investigator)
Conditions: -
Caroline ROUSSET-ROUVIERE, MD PHDSeen in:
- Marseille, AP-HM - Timone Enfants
Trials:- NCT03919981 (Principal Investigator)
- NCT06225882 (Principal Investigator)
-
Cécile ACQUAVIVA, MDSeen in:
- Strasbourg, Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg
Trials:- NCT05107830 (Sub-Investigator)
Conditions: -
Francois NOBILI, MD,PhDSeen in:
- Besançon, CHU de Besancon
Trials:- NCT03919981 (Principal Investigator)
- NCT06225882 (Principal Investigator)
-
Justine BACCHETTA, MDSeen in:
- Bron, Centre de Référence des Maladies Rénales Rares - Hospices Civils de Lyon - Service de Néphrologie et Rhumatologie Pédiatriques - Hôpital Femme Mère Enfant
- Bron, Hospice Civil de Lyon
- Lyon, Edouard Herriot Hospital, HCL
- Strasbourg, Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg
Trials:- NCT03582800 (Principal Investigator)
- NCT06225882 (Principal Investigator)
- NCT02838927 (Sub-Investigator)
- NCT05107830 (Sub-Investigator)
-
Olivia BOYER, MD PHDSeen in:
- Paris, CHU Paris - Hôpital Necker-Enfants Malades
Trials:- NCT03919981 (Sub-Investigator)
- NCT06225882 (Sub-Investigator)
-
Romain PSZCZOLINSK, MDSeen in:
- Strasbourg, Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg
Trials:- NCT05107830 (Sub-Investigator)
Conditions: -
Sandrine LEMOINE, PU-PHSeen in:
- Lyon, Hôpital Edouard Herriot
Trials:- NCT05923788 (Principal Investigator)
- NCT06225882 (Principal Investigator)
Clinical Trials on Hyperoxaluria, Primary
-
Dicerna Pharmaceuticals, Inc.CompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United Kingdom, New Zealand, United States, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)France, United Kingdom, Netherlands, Israel, Germany
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
VA New York Harbor Healthcare SystemMayo Clinic; New York UniversityUnknownOxalate, Primary Hyperoxaluria, MicrobiomeUnited States
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary Hyperoxaluria Type 3United States, Germany, Netherlands, United Kingdom
-
University of CologneCompletedPrimary Hyperoxaluria Type IGermany
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 (PH1) | Primary HyperoxaluriaUnited States, France, United Kingdom, Israel, Germany
-
Alnylam PharmaceuticalsCompletedPrimary Hyperoxaluria Type 1 (PH1)United States, France, United Kingdom, Switzerland, Netherlands, Israel, Germany, United Arab Emirates
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)